ATE421971T1 - Isostere transformation - Google Patents

Isostere transformation

Info

Publication number
ATE421971T1
ATE421971T1 AT05728233T AT05728233T ATE421971T1 AT E421971 T1 ATE421971 T1 AT E421971T1 AT 05728233 T AT05728233 T AT 05728233T AT 05728233 T AT05728233 T AT 05728233T AT E421971 T1 ATE421971 T1 AT E421971T1
Authority
AT
Austria
Prior art keywords
terminal
group
amino group
carboxy
isosteric
Prior art date
Application number
AT05728233T
Other languages
English (en)
Inventor
Hans-Georg Frank
Karsten Knorr
Udo Haberl
Andreas Rybka
Original Assignee
Aplagen Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34924503&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE421971(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aplagen Gmbh filed Critical Aplagen Gmbh
Application granted granted Critical
Publication of ATE421971T1 publication Critical patent/ATE421971T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
AT05728233T 2004-03-17 2005-03-17 Isostere transformation ATE421971T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04006354 2004-03-17

Publications (1)

Publication Number Publication Date
ATE421971T1 true ATE421971T1 (de) 2009-02-15

Family

ID=34924503

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05728233T ATE421971T1 (de) 2004-03-17 2005-03-17 Isostere transformation

Country Status (8)

Country Link
US (1) US20080305985A1 (de)
EP (1) EP1725580B1 (de)
JP (1) JP2007529475A (de)
AT (1) ATE421971T1 (de)
DE (1) DE602005012575D1 (de)
DK (1) DK1725580T3 (de)
SI (1) SI1725580T1 (de)
WO (1) WO2005090389A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI415628B (zh) * 2006-02-28 2013-11-21 Avon Prod Inc 包含具有非天然胺基酸之胜肽之組合物及其使用方法
PL2352508T3 (pl) * 2008-10-17 2014-09-30 Dana Farber Cancer Inst Inc Peptydy domeny cytoplazmatycznej MUC-1 jako inhibitory nowotworu
US11322228B2 (en) * 2015-10-30 2022-05-03 Janssen Vaccines & Prevention B.V. Structure based design of d-protein ligands
CN113166203A (zh) * 2018-09-14 2021-07-23 Epo医药株式会社 抗促红细胞生成素受体肽

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1206339B (it) * 1984-01-13 1989-04-14 Anic Spa Analoghi retro-invertiti esapeptidici c-terminali della sostanza p.
US5773569A (en) * 1993-11-19 1998-06-30 Affymax Technologies N.V. Compounds and peptides that bind to the erythropoietin receptor
ATE254138T1 (de) * 1995-06-07 2003-11-15 Ortho Pharma Corp An den erythropoietin-rezeptor bindende zusammensetzungen und peptide
EP1252181B1 (de) * 2000-01-20 2006-01-18 Regents Of The University Of Minnesota Peptide mit antibakterieller wirkung

Also Published As

Publication number Publication date
DE602005012575D1 (en) 2009-03-19
EP1725580A2 (de) 2006-11-29
US20080305985A1 (en) 2008-12-11
WO2005090389A2 (en) 2005-09-29
JP2007529475A (ja) 2007-10-25
EP1725580B1 (de) 2009-01-28
DK1725580T3 (da) 2009-03-23
SI1725580T1 (sl) 2009-06-30
WO2005090389A3 (en) 2006-05-11

Similar Documents

Publication Publication Date Title
ES2616658T3 (es) Péptidos que mimetizan el factor de crecimiento y sus usos
ES2571879T3 (es) Moléculas de una sola cadena de TNFSF
WO2024119724A9 (zh) 胶原蛋白肽及其制备方法和用途
IN2014CN02050A (de)
WO2007127977A3 (en) Methods of evaluating peptide mixtures
WO2010059051A3 (en) Rapid fret-based diagnosis of bacterial pathogen
ES2531142T3 (es) Péptidos WT1 de unión a HLA de clase II, y composiciones y métodos que los comprenden
EP1801206A4 (de) Verfahren zur herstellung von l-arginin, l-ornithin oder l-citrullin
WO2009069808A1 (ja) 新規活性を有するEphA4ポリペプチドおよびその用途
DE60335726D1 (de) Chromoprotein und fluoroproteine
WO2006054262A3 (en) Use of phage display technique for identifying peptides capable of binding progenitor/stem cells, peptides thereby obtained and uses thereof
DE602007004110D1 (de) Hausstaubmilbenallergen
CY1111630T1 (el) Παραγωγα κυτοκινων
ES2507094T3 (es) Proteína específica del timo
RU2010142486A (ru) Частичный пептид лакритина
ATE394411T1 (de) Verfahren zur synthese und selektiven biokatalytischen modifizierung von peptiden, peptidmimetika und proteinen
ATE421971T1 (de) Isostere transformation
MX2010005816A (es) Epítopos de péptido de stat3.
ES2557938T3 (es) Antagonistas de resistina y su uso
ATE474589T1 (de) Angiogene peptide und ihre verwendungen
NZ591133A (en) Novel melanoma antigen peptide and uses thereof
NO20081503L (no) T-celle adhesjonsmolekyl, og antistoff dertil
NO20082864L (no) Nytt polypeptid med esteraseaktivitet og rekombinant esterase samt anvendelse derav
DE602005018326D1 (de) Für orotat-transporter codierende markergene
RU2008107183A (ru) Композиция, имеющая активность ингибитора ангиогенеза

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties